Issues about the rationality of subject selection of aspirin and proton pump inhibitor fixed dose combination
10.13699/j.cnki.1001-6821.2015.24.042
- VernacularTitle:质子泵抑制剂和阿司匹林固定剂量复方制剂的立题合理性探讨
- Author:
Ying CHEN
1
;
Tao WANG
;
Shui-Qiang WANG
Author Information
1. 国家食品药品监督管理总局 药品审评中心
- Keywords:
aspirin;
proton pump inhibitor;
fixed dose combination
- From:
The Chinese Journal of Clinical Pharmacology
2015;(24):2502-2506
- CountryChina
- Language:Chinese
-
Abstract:
Aspirin decreases the risk of cardiovascular thrombotic events, however, one of the side-effects associated with this use is serious gas-trointestinal adverse events, which can be fatal.Proton pump inhibitor ( PPI) is used for healing of ulcers and prevention of non-steroidal anti-inflammatory drug -associated gastric ulcer. In this article, we discuss the issues about the rationality of subject selection of aspirin and PPI fixed dose combination.